SCI Pharmtech, Inc.

4119

TW0004119003

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 03:30:00 07/05/2024 am IST			5-day change	1st Jan Change
88.1 ^TWD	-0.45%		-1.01%	-8.99%

20/03	SCI Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	SCI Pharmtech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Sci Pharmtech, Inc. Proposes Cash Dividend for the Year Ended 31 December 2022

March 14, 2023 at 01:41 pm IST

SCI Pharmtech, Inc. proposed cash dividend of TWD 0.25 per share and Total amount of cash distributed to shareholders TWD 23,845,593 for the year ended 31 December 2022.

Latest news about SCI Pharmtech, Inc.

SCI Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
SCI Pharmtech, Inc. announced that it expects to receive TWD 120 million in funding	25/23/25	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/23/10	CI
SCI Pharmtech, Inc. Announces Cash Dividend, Payable on September 1, 2023	05/23/05	CI
SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Sci Pharmtech, Inc. Proposes Cash Dividend for the Year Ended 31 December 2022	14/23/14	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/22/10	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	10/22/10	CI
SCI Pharmtech, Inc. Announces Appointment of General Manager of the Board of Directors	29/22/29	CI
SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	07/22/07	CI
SCI Pharmtech, Inc. Proposes No Earnings Distribution for the Year Ended December 31, 2021	18/22/18	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	18/22/18	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	05/21/05	CI
Sci Pharmtech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	07/21/07	CI
Sci Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	06/21/06	CI
Sci Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	24/21/24	CI
Sci Pharmtech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	06/20/06	CI
SCI Pharmtech, Inc. Announces Dividend, Payable on August 18, 2020	24/20/24	CI
Sci Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	08/20/08	CI
SCI Pharmtech, Inc. Proposes Dividend Distribution	13/20/13	CI
Sci Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	13/20/13	CI
Sci Pharmtech, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	13/19/13	CI
Energenesis Biomedical CO.,LTD. announced that it expects to receive TWD 19.9962 million in funding from SCI Pharmtech, Inc.	25/19/25	CI
Sci Pharmtech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	13/19/13	CI

SCI Pharmtech, Inc. is a Taiwan-based company principally engaged in the processing, manufacture and sales of Active Pharmaceutical Ingredients (APIs). The Company's main products include APIs, API intermediates and special and precision chemicals. The Company distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Sector

Pharmaceuticals

Calendar

10/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
SCI PHARMTECH, INC.	-8.99%	325M
MERCK KGAA	+7.08%	71.94B
KYOWA KIRIN CO. LTD.	+11.16%	9.27B
SK BIOPHARMACEUTICALS CO., LTD.	-11.55%	5.13B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+48.05%	4.66B
YUHAN CORPORATION	+5.09%	3.97B
BETTA PHARMACEUTICALS CO., LTD.	-14.74%	2.55B
INDIVIOR PLC	+18.57%	2.41B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-24.89%	2.36B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+21.45%	2.21B

Specialty & Advanced Pharmaceuticals